Expert Interviews

September 25, 2020

The use of biologics, JAK inhibitors and small molecule medications has become increasingly common for patients with psoriatic arthritis. Findings from the recent Psoriatic Arthritis In America 2020 survey by Health Union shows that of 1,120 patients surveyed, most patients (61 percent) are satisfied with the care they receive from their doctors, but they still struggle with flares and only 12 percent are satisfied with their care plan. In this interview, Brian Green, vice president of community development at Health Union, reviews the results of their latest survey.

September 18, 2020

Today, we talk with Dr. Sarah French, a rheumatologist with the University of California at San Francisco. Dr. French recently published a review in Current Osteoporosis Reports that addresses successes and failures in quality improvement initiatives in osteoporosis. Through the MIPS program, healthcare providers are required to select six quality measures. And while they may be performing well on osteoporosis screenings, their track record on osteoporosis management isn't fairing as well. Dr. French has identified this as an area for improvement. In this interview, she explains how.

September 18, 2020

In today’s one-on-one interview, we talk with Dr. Richard Furie who is chief of rheumatology at Northwell Health in New York. Dr. Furie is the lead investigator of a study on lupus nephritis just published in the New England Journal of Medicine. Dr. Furie and colleagues from the Feinstein Institutes for Medical Research reported that belimumab with standard therapy has been shown to be an effective treatment for lupus nephritis. If the treatment is approved by the U.S. Food and Drug Administration, it would be the first of its kind for this condition. In this presentation, Dr. Furie tell us more.

September 03, 2020

Hip fractures in the United States and developed countries have been declining for over four decades. But why? Dr. Timothy Bhattacharyya, an orthopedic surgeon and head of Orthopedics Research for the Clinical Trials and Outcomes Branch of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, delved into the root cause of this phenomenon in a study published in July in JAMA Internal Medicine.

August 28, 2020

In this week's one-on-one interview, we talk with Dr. Jeffrey Curtis of the University of Alabama. We spoke about the use of activity trackers as a tool to record and track arthritic flare-ups. The device has been found to be useful in improving patient care or as Dr. Curtis says, “we need to right-size care” by giving patients the right care at the right time.” In this interview, he explains how an activity tracker can make such a huge difference in the care patients receive.

August 21, 2020

In this week's news roundup from Rheumatology Network, we highlight a one-on-one discussion with Dr. Fotios Koumpouras, fellowship program director for rheumatology at Yale School of Medicine. Rheumatology education has undergone some changes since the start of the pandemic, he says. In this interview, he tells us how.

August 17, 2020

TeleECHO educational programs for healthcare providers have successfully trained physicians and other healthcare providers to fulfill the unmet needs of patients without access to specialty care, particularly osteoporosis care. In this interview with Dr. Michael Lewiecki, he introduces us to Bone Health TeleECHO. He tells us how the program works, why it’s needed and how you can launch one in your state.

August 14, 2020

In this week's news roundup from Rheumatology Network, we feature a one-on-one interview with Dr. Michael Lewiecki of the New Mexico Clinical Research and Osteoporosis Center. He heads a virtual learning program called Bone Health TeleECHO and in this interview, he tells us how the program works, why it’s needed and how you, as a physician, can launch one in your state.

August 07, 2020

In this week's news roundup and one-on-one interview, we talk with Dr. Daniel Solomon of Brigham and Women’s Hospital and editor-in-chief of the journal Arthritis and Rheumatology. Dr. Solomon and colleagues recently published a commentary called “The Infodemic of COVID-19” in which they break down the inundation of new science on hydroxychloroquine and the cytokine storm.

July 13, 2020

In this week’s news roundup from Rheumatology Network, we highlight our most popular stories of the week including a one-on-one discussion with Dr. Vibeke Strand, a rheumatologist, immunologist and biopharmaceutical consultant who has conducted clinical trials on JAK inhibitors for rheumatoid arthritis. In this interview, Dr. Strand discusses this and other treatments in development for rheumatoid arthritis.

July 01, 2020

All good relationships are built on solid foundations, including the doctor-patient relationship. In this interview with Dr. Candace Feldman, M.D., MPH, ScD, of Brigham and Women’s Hospital in Boston, we explore factors that may impinge good outcomes for lupus patients.

June 19, 2020

In this week's news roundup from Rheumatology Network, we feature a series of studies that focus on new treatments for rheumatic disease. We also highlight the newly approved secukinumab (Cosentyx, Novartis) for active non-radiographic axial spondyloarthritis (axSpA). Today, we feature a discussion with Dr. Alexis Ogdie-Beatty and Kelly Gavigan, the lead researcher on a recent study about the overlap between axSpA and fibromyalgia.

April 24, 2020

April 14, 2020

July 07, 2017

Patients with higher MRI inflammation in hand and wrist RA may derive greater benefit from abatacept with methotrexate instead of methotrexate alone.

June 30, 2017

In contradiction to long-standing beliefs, a healthy pregnancy is possible for women who have lupus, Dr. Jill Buyon says.

June 30, 2017

One in 50 women with lupus could have a child with neonatal lupus, but preventative steroid therapy may be unnecessary.

October 25, 2016

Is this on your radar? A herpes zoster infection can lead to stroke in some RA patients. Learn more in this interview with Dr. Jeffrey Curtis.

August 10, 2016

Obesity was a common theme at RNS16 this year in which speakers touched on obesity as a cause of disease onset and even as one that can prevent therapeutic treatments from working.

November 12, 2015

In this interview, Herbert S. B. Baraf, MD, FACP, MACR, provides his take-a-ways from ACR/ARHP 2015 about new reimbursement policies affecting private practice rheumatologists.